Delivery Order SPE2DB20D1100-SPE2DB24FA6P4
Award Date 3/11/24
Potential Completion Date 3/12/24
Potential Value $2.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,514.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NUCYNTA ER 100 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $1,155.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NUCYNTA 50 MG TABLET 100S. The delivery order is part of an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NUCYNTA ER 100 MG Tablet 60s. The contract has a ceiling value of $4,312.38 and a period of performance through April 5, 2024. This delivery order award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) has awarded a $1,388.98 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of NUCYNTA ER 100 MG TABLET 60S, a prescription pharmaceutical product. This delivery order was issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00, to provide pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NUCYNTA ER 100 MG TABLET 60S. The contract, valued at $2,083.47, runs through March 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside for any specific business type. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NUCYNTA 50 MG TABLET 100S. The contract has a potential value of $1,155.92 and a completion date of February 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NUCYNTA ER 250 MG TABLET 60S. The order has a potential value of $2,640.92 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set aside. The company also holds an indefinite delivery contract (IDC) with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,497.95 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,766,357 units of NUCYNTA 100 MG TABLET 100S, a pharmaceutical product, with a period of performance through September 12, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical for delivering a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,155.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NUCYNTA 50 MG TABLET 100S. The contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) also held by Amerisourcebergen Drug Corp, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product NUCYNTA ER 50 MG TABLET 60S. The contract, valued at $2,408.72, will run through April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside. The company also holds an Indefinite Delivery Contract (IDC) with DLA, valued...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA6P4Delivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $2,526.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4563925299 - NUCYNTA ER 100 MG TABLET 60S. This order is placed under an existing $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside designation and is expected to be completed by March 12, 2024.
Generated 6/10/24, 9:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 3/11/24 |